Full Text View
Tabular View
Study Results
Related Studies
90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions
This study has been completed.
Study NCT01247285   Information provided by Teva Pharmaceuticals USA

First Received on November 22, 2010.   Last Updated on January 24, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Fluoxetine Hydrochloride
PROZAC WEEKLY®
Additional drug interventions recognized in this trial
Fluoxetine
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Teva Pharmaceuticals USA


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services